Home

Satisfaire Mécaniquement Effrayant catalent press release balcon argile James Dyson

Press Release
Press Release

Catalent, Inc. 2023 Q1 - Results - Earnings Call Presentation (NYSE:CTLT) |  Seeking Alpha
Catalent, Inc. 2023 Q1 - Results - Earnings Call Presentation (NYSE:CTLT) | Seeking Alpha

Biohaven Announces Exclusive License With Catalent For Zydis® Orally  Dissolving Tablet With Small Molecule CGRP Receptor Antagonists
Biohaven Announces Exclusive License With Catalent For Zydis® Orally Dissolving Tablet With Small Molecule CGRP Receptor Antagonists

TFF Pharmaceuticals and Catalent Announce New Inhalation Dry Powder  Development and Manufacturing Agreement
TFF Pharmaceuticals and Catalent Announce New Inhalation Dry Powder Development and Manufacturing Agreement

Bloomington's Catalent to hire 1,000 new employees paying on average $32  per hour, and invest at least $350 million | WBIW
Bloomington's Catalent to hire 1,000 new employees paying on average $32 per hour, and invest at least $350 million | WBIW

Catalent Pharma on Twitter: "Catalent Development San Diego wins 4 awards  in the 'Small Pharma' categories of the 2018 CMO Leadership Awards. View  the full press release here: https://t.co/TNzKZWiiic #CMOLeadershipAwards # Catalent #pharmasolutions
Catalent Pharma on Twitter: "Catalent Development San Diego wins 4 awards in the 'Small Pharma' categories of the 2018 CMO Leadership Awards. View the full press release here: https://t.co/TNzKZWiiic #CMOLeadershipAwards # Catalent #pharmasolutions

Catalent pulls off $1.2B deal for gene therapy CDMO Paragon Bioservices |  Fierce Pharma
Catalent pulls off $1.2B deal for gene therapy CDMO Paragon Bioservices | Fierce Pharma

Labconco Equipment Used to Speed Up Drug Discovery - Labconco
Labconco Equipment Used to Speed Up Drug Discovery - Labconco

News and Events - Catalent
News and Events - Catalent

Technology, not capacity, driving Catalent's biologics strategy
Technology, not capacity, driving Catalent's biologics strategy

Catalent Invests Additional $230 Million to Expand its State-of-the-Art  Gene Therapy Commercial Manufacturing Campus in Harmans, Maryland · BioBuzz
Catalent Invests Additional $230 Million to Expand its State-of-the-Art Gene Therapy Commercial Manufacturing Campus in Harmans, Maryland · BioBuzz

Perrigo and Catalent Announce FDA Approval of Perrigo's AB-Rated Generic  Version of ProAir® HFA | corporate
Perrigo and Catalent Announce FDA Approval of Perrigo's AB-Rated Generic Version of ProAir® HFA | corporate

Definitive Proxy Statement
Definitive Proxy Statement

Catalent Appoints Ricardo Zayas as North American Biologics Operations  Leader | Business Wire
Catalent Appoints Ricardo Zayas as North American Biologics Operations Leader | Business Wire

Catalent increases spray drying capacity at Pharmatek
Catalent increases spray drying capacity at Pharmatek

Saint-Gobain launches glass circular economy program at 2 facilities in  California - Recycling Today
Saint-Gobain launches glass circular economy program at 2 facilities in California - Recycling Today

Perrigo and Catalent Announce FDA Approval of Generic ProAir® HFA
Perrigo and Catalent Announce FDA Approval of Generic ProAir® HFA

Exelixis and Catalent Enter into Collaboration, License, and Exclusive  Option Agreement to Develop Antibody-Drug Conjugates Leve
Exelixis and Catalent Enter into Collaboration, License, and Exclusive Option Agreement to Develop Antibody-Drug Conjugates Leve

Catalent To Open New Clinical Supply Facility In San Diego | World Pharma  Today
Catalent To Open New Clinical Supply Facility In San Diego | World Pharma Today

Catalent Biologics - BIO International Convention | BIO
Catalent Biologics - BIO International Convention | BIO

Juniper Pharmaceuticals Signs Definitive Agreement to be Acquired by  Catalent, Inc. for $11.50 Per Share in Cash
Juniper Pharmaceuticals Signs Definitive Agreement to be Acquired by Catalent, Inc. for $11.50 Per Share in Cash

Bloomington's Catalent to Hire 1,000 New Employees at Average Wages of $32  an Hour or More, and Invest at Least $350 Million | City of Bloomington,  Indiana
Bloomington's Catalent to Hire 1,000 New Employees at Average Wages of $32 an Hour or More, and Invest at Least $350 Million | City of Bloomington, Indiana

ERYTECH Provides Business and Financial Update for the First Half of 2022
ERYTECH Provides Business and Financial Update for the First Half of 2022

Catalent to manufacture Moderna's personalized cancer vaccine
Catalent to manufacture Moderna's personalized cancer vaccine